Skip to Main Content

Author Details

Raul Andino
University of California san francisco
1981
163
67
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35233577Type I interferon responsive microglia shape cortical development and behavior.bioRxiv2023
37487061High-resolution mapping reveals the mechanism and contribution of genome insertions and deletions to RNA virus evolution.Proc Natl Acad Sci U S A2023
37849401The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.J Infect Dis2023
37502856Monitoring integrated stress response in live <i>Drosophila</i>.bioRxiv2023
37978288A tradeoff between enterovirus A71 particle stability and cell entry.Nat Commun2023
37636517Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron Era.Open Forum Infect Dis2023
37461541SARS-CoV-2 Nsp1 regulates translation start site fidelity to promote infection.bioRxiv2023
37316671Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.Nature2023
37338211Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage.mSphere2023
37236881Reconsidering life history theory amid infectious diseases.Trends Ecol Evol2023
36697369Positive-strand RNA viruses-a Keystone Symposia report.Ann N Y Acad Sci2023
36580912SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.Cell2023
36608647Polio eradication: Addressing the hurdles on the last mile.Cell2023
36604514Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2.Nat Microbiol2023
36705269Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022.J Infect Dis2023
35149714Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.NPJ Vaccines2022
35584773Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.Nature2022
35788827Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort Study.Clin Infect Dis2022
36417857Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes.Cell Rep2022
36455064Targeting Nup358/RanBP2 by a viral protein disrupts stress granule formation.PLoS Pathog2022
36332645Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.Lancet Microbe2022
36134603Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.J Infect Dis2022
36096982Could aging evolve as a pathogen control strategy?Trends Ecol Evol2022
36156706Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.JAMA2022
34081912SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.Cell Metab2021
33491648Principles of dengue virus evolvability derived from genotype-fitness maps in human and mosquito cells.Elife2021
33758899Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.medRxiv2021
34852237A defective viral genome strategy elicits broad protective immunity against respiratory viruses.Cell2021
34675396Author Correction: Cotranslational prolyl hydroxylation is essential for flavivirus biogenesis.Nature2021
34408324Cotranslational prolyl hydroxylation is essential for flavivirus biogenesis.Nature2021
34468175Intra- and Inter-cellular Modeling of Dynamic Interaction between Zika Virus and Its Naturally Occurring Defective Viral Genomes.J Virol2021
34604819Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers.Cell Rep Med2021
34570820Experimental and mathematical insights on the interactions between poliovirus and a defective interfering genome.PLoS Pathog2021
34478458Ethacridine inhibits SARS-CoV-2 by inactivating viral particles.PLoS Pathog2021
33991487Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.Cell2021
34153975In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.Nature2021
34362936Examining the interplay between face mask usage, asymptomatic transmission, and social distancing on the spread of COVID-19.Sci Rep2021
34195600Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine.Vaccine X2021
32330425Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.Cell Host Microbe2020
33140048Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models.bioRxiv2020
33232663Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.Cell Stem Cell2020
32962398Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity.AIDS Res Hum Retroviruses2020
32651271Epidemics as an adaptive driving force determining lifespan setpoints.Proc Natl Acad Sci U S A2020
32958861Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination.Sci Rep2020
32784424Mapping Attenuation Determinants in Enterovirus-D68.Viruses2020
32814037Species-Specific Evolution of Ebola Virus during Replication in Human and Bat Cells.Cell Rep2020
32218998Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.NPJ Vaccines2020
30673613Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy against Infection and Disease.Cell Rep2019
31527793Enterovirus pathogenesis requires the host methyltransferase SETD3.Nat Microbiol2019
31174831The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.Lancet2019
  • 1 - 50 of 163

Recommended Authors

Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year 2017
Number of shared co-authors 12
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 4
University of Oxford
Career Start Year 2013
Number of shared co-authors 1
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 12
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 20
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 1
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 6
University of North Carolina
Career Start Year 2004
Number of shared co-authors 6
University of Cambridge
Career Start Year 2003
Number of shared co-authors 3
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 11
University of Utah School of Medicine
Career Start Year 2001
Number of shared co-authors 4
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 15
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 10
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Campus Universidad Autonoma de Madrid
Career Start Year 1999
Number of shared co-authors 1
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 21
carnegie mellon university
Career Start Year 1996
Number of shared co-authors 1
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 8
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 3
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 13
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 7
University College London
Career Start Year 1992
Number of shared co-authors 2
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1989
Number of shared co-authors 34
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 5
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 13
Rockefeller University
Career Start Year 1981
Number of shared co-authors 13
University of North Carolina
Career Start Year 1981
Number of shared co-authors 17

Collaborators

Stanford University
Co-authored papers 13
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 10
Fundacion Instituto Leloir-CONICET
Co-authored papers 9
University of Michigan ann arbor
Co-authored papers 7
Stanford University School of Medicine, Center for Clinical Sciences Research
Co-authored papers 7
Co-authored papers 6
Gladstone Institute of Virology
Co-authored papers 5
University of California-San Francisco
Co-authored papers 4
Gladstone Institute of Virology
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Gladstone Institutes
Co-authored papers 3
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 3
Gladstone Institutes
Co-authored papers 3
West China Hospital, Sichuan University
Co-authored papers 3
Addenbrooke's Hospital, University of Cambridge
Co-authored papers 2
Gladstone Institute of Virology, Gladstone Institutes San Francisco CA USA .
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California berkeley
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2
University of CaliforniaSan Francisco
Co-authored papers 2
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Institute for Neurodegenerative Diseases, University of California San Francisco
Co-authored papers 2
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2